ORCA
Online Research @ CardiffÂ
Browse by Current Cardiff authors
![[up]](/style/images/multi_up.png)
Up a levelNumber of items: 3.
Dodd, Katherine C., Baillie, Kirsten, Holt, James K.L., Leite, M. Isabel, Lin, Lijing, West, Peter W., Miller, James A.L., Spillane, Jennifer, Viegas, Stuart, Zelek, Wioleta M., Sussman, Jon and Menon, Madhvi
2026.
Lymphocyte alterations and elevated complement signaling are key features of refractory myasthenia gravis.
Med
, 100987.
10.1016/j.medj.2025.100987
|
|
Keat, Samuel B. K., Khatri, Priyanka, Ali, Youssif M., Arachchilage, Chanuka H., Demopulos, Gregory, Baillie, Kirsten, Miners, Kelly L., Ladell, Kristin  ORCID: https://orcid.org/0000-0002-9856-2938, Jones, Samantha A., Davies, Helen E., Price, David A. ORCID: https://orcid.org/0000-0001-9416-2737, Zelek, Wioleta M., Morgan, B. Paul ORCID: https://orcid.org/0000-0003-4075-7676, Schwaeble, Wilhelm J. and Lynch, Nicholas J.
2026.
Activation of the lectin pathway drives persistent complement dysregulation in long COVID.
Immunology
10.1111/imm.70110
|
|
|
|
Baillie, Kirsten, Davies, Helen E., Keat, Samuel B. K., Ladell, Kristin ORCID: https://orcid.org/0000-0002-9856-2938, Miners, Kelly L., Jones, Samantha A., Mellou, Ermioni, Toonen, Erik J. M., Price, David A. ORCID: https://orcid.org/0000-0001-9416-2737, Morgan, B. Paul ORCID: https://orcid.org/0000-0003-4075-7676 and Zelek, Wioleta M.
2024.
Complement dysregulation is a prevalent and therapeutically amenable feature of long COVID.
Med
5
(3)
, pp. 239-253.
10.1016/j.medj.2024.01.011
|
|
|